Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Phibro Animal Health (PAHC) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY26 Guidance
February 4, 2026 4:27 PM ESTPhibro Animal Health (NASDAQ: PAHC) reported Q2 EPS of $0.87, $0.19 better than the analyst estimate of $0.68. Revenue for the quarter came in at $373.9 million versus the consensus estimate of $355.24 million.
GUIDANCE:
Phibro Animal Health sees FY2026 EPS of $2.93-$3.10, versus the... More
